- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancers 2021, 13(22), 5744; https://doi.org/10.3390/cancers13225744
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2022
- Urheber
- DOI
-
10.3390/cancers13225744
- URN
-
urn:nbn:de:bvb:20-opus-250121
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lindner, Thomas
- Giesel, Frederik L.
- Kratochwil, Clemens
- Serfling, Sebastian E.
- Universität Würzburg
Entstanden
- 2022
Ähnliche Objekte (12)
Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators
18F-labeled tracers targeting fibroblast activation protein
Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA
Adoptiv transferierte T-Zellen mit FAP(fibroblast activation protein)-Spezifität verhindern die Tumoretablierung
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review
High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer
Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects
Targeting the tumor microenvironment with fluorescence-activatable bispecific endoglin/fibroblast activation protein targeting liposomes
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
miR-27b inhibits fibroblast activation via targeting TGFβ signaling pathway
Humane Antikörperderivate gegen das Tumorstroma-Antigen Fibroblast-activation-Protein
Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators
18F-labeled tracers targeting fibroblast activation protein
Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA
Adoptiv transferierte T-Zellen mit FAP(fibroblast activation protein)-Spezifität verhindern die Tumoretablierung
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review
High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer
Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects
Targeting the tumor microenvironment with fluorescence-activatable bispecific endoglin/fibroblast activation protein targeting liposomes
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
miR-27b inhibits fibroblast activation via targeting TGFβ signaling pathway
Humane Antikörperderivate gegen das Tumorstroma-Antigen Fibroblast-activation-Protein
Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators
18F-labeled tracers targeting fibroblast activation protein
Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA
Adoptiv transferierte T-Zellen mit FAP(fibroblast activation protein)-Spezifität verhindern die Tumoretablierung
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review
High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer
Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects
Targeting the tumor microenvironment with fluorescence-activatable bispecific endoglin/fibroblast activation protein targeting liposomes
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
miR-27b inhibits fibroblast activation via targeting TGFβ signaling pathway